Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tyrosinase and tyrosinase-related protein-1 (TRP-1) are two melanogenic enzymes that regulate melanin biosynthesis. Both are glycoproteins and belong to the TRP-1 gene family. They share a significant level of sequence similarity in several regions, including the catalytic domain and the potential N-glycosylation sites. We have recently shown that inhibition of the early steps of N-glycan processing in B16F1 cells dramatically affects
tyrosinase
activity and melanin synthesis. We present here results on N-glycan processing of TRP-1 and
tyrosinase
and compare the maturation process and activity of both glycoproteins in the presence of inhibitors of the endoplasmic reticulum stages of N-glycosylation. N-glycan analysis reveals that each of these two glycoproteins contains a mixture of high-mannose and sialylated complex N-glycans. However, in contrast to TRP-1,
tyrosinase
presents a homogeneous high-mannose glycoform, also. In the presence of alpha-glucosidases inhibitors, the maturation of
tyrosinase
N-glycans is completely inhibited, whereas TRP-1 is still able to acquire some complex glycans, indicating that
endomannosidase
acts preferentially on the later glycoprotein. In addition, the dopa-oxidase activity of
tyrosinase
is totally abolished, whereas for TRP-1 it is only partially affected. The results suggest that despite their structural similarity,
tyrosinase
is more sensitive than TRP-1 to perturbations of early N-glycan processing, in terms of maturation and catalytical activity.
...
PMID:Protein specific N-glycosylation of tyrosinase and tyrosinase-related protein-1 in B16 mouse melanoma cells. 1058 52